AA
AlphaCentric Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-32,500
| Closed | -$2.28M | – | 219 |
|
|
2024
Q3 | $2.28M | Buy |
32,500
+16,000
| +97% | +$1.12M | 1.7% | 11 |
|
|
2024
Q2 | $1.36M | Buy |
16,500
+1,000
| +6% | +$82.3K | 1% | 31 |
|
|
2024
Q1 | $1.35M | Buy |
15,500
+1,500
| +11% | +$131K | 0.82% | 48 |
|
|
2023
Q4 | $1.35M | Sell |
14,000
-2,500
| -15% | -$241K | 0.91% | 40 |
|
|
2023
Q3 | $1.46M | Hold |
16,500
| – | – | 0.83% | 39 |
|
|
2023
Q2 | $1.43M | Buy |
16,500
+11,000
| +200% | +$953K | 0.79% | 47 |
|
|
2023
Q1 | $535K | Buy |
+5,500
| New | +$535K | 0.37% | 85 |
|
|
2021
Q4 | $839K | Buy |
9,500
+1,500
| +19% | +$132K | 0.24% | 41 |
|
|
2021
Q3 | $618K | Hold |
8,000
| – | – | 0.16% | 56 |
|
|
2021
Q2 | $668K | Hold |
8,000
| – | – | 0.18% | 45 |
|
|
2021
Q1 | $604K | Buy |
8,000
+500
| +7% | +$37.8K | 0.2% | 38 |
|
|
2020
Q4 | $658K | Buy |
7,500
+5,250
| +233% | +$461K | 0.27% | 22 |
|
|
2020
Q3 | $171K | Buy |
+2,250
| New | +$171K | 0.08% | 50 |
|